Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad.

The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA.

In March 2020, Laurus Labs received US Food and Drug Administration approval to market hydroxychloroquine tablets.

[11] Laurus Labs claims to be the "world's largest third party API supplier for anti-retrovirals" and has one of the largest[12] HiPotent API capacities in India[13] The company also makes Dolutegravir/lamivudine/tenofovir, a medication for HIV/AIDS,[14][15] and hydroxychloroquine tablets, which are used to treat certain types of malaria.

Laurus Labs entered the biotechnology sector in 2020, by acquiring the Indian biotech company, Richcore.